{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T03:14:52Z","timestamp":1778210092424,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Fujian Provincial Science and Technology Innovation Joint Project","award":["No. 2024Y9662"],"award-info":[{"award-number":["No. 2024Y9662"]}]},{"name":"the Natural Science Foundation of Fujian Province","award":["No. 2024J011155"],"award-info":[{"award-number":["No. 2024J011155"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00794-4","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T06:19:38Z","timestamp":1776320378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High INHBB expression in colorectal cancer is associated with poor prognosis and drives malignant phenotypes in tumor cells"],"prefix":"10.1186","volume":"21","author":[{"given":"Huiyan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongxuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"issue":"10449","key":"794_CR1","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0140-6736(24)00360-X","volume":"404","author":"C Eng","year":"2024","unstructured":"Eng C, Yoshino T, Ru\u00edz-Garc\u00eda E, et al. Colorectal cancer. Lancet. 2024;404(10449):294\u2013310.","journal-title":"Lancet"},{"issue":"7","key":"794_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer:A review. JAMA. 2021;325(7):669\u201385.","journal-title":"JAMA"},{"issue":"1","key":"794_CR3","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A, Cancer statistics. CA Cancer J Clin 2024 Jan-Feb. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin 2024 Jan-Feb"},{"key":"794_CR4","unstructured":"Recio\u2013Boiles A, Cagir B. Colon Cancer. StatPearls. Treasure Island (FL):StatPearls Publishing Copyright \u00a9 2022, StatPearls Publishing LLC;2022."},{"issue":"1","key":"794_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12935-025-04039-8","volume":"25","author":"G Noorkhajavi","year":"2025","unstructured":"Noorkhajavi G, Banakholdi A, Torabi A, Zoghi A, Iranijam E, Safarzadeh E. Recent clinical advances in nonconjugated antibodies and antibody-drug conjugates for colorectal cancer treatment. Cancer Cell Int. 2025;25(1):395.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"794_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12957-022-02549-7","volume":"20","author":"X Zhang","year":"2022","unstructured":"Zhang X, Yang Z, An Y, et al. Clinical benefits of PD-1\/PD-L1 inhibitors in patients with metastatic colorectal cancer: a systematic review and meta-analysis. World J Surg Oncol. 2022;20(1):93.","journal-title":"World J Surg Oncol"},{"key":"794_CR7","doi-asserted-by":"publisher","first-page":"103663","DOI":"10.1016\/j.critrevonc.2022.103663","volume":"173","author":"AE Boukouris","year":"2022","unstructured":"Boukouris AE, Theochari M, Stefanou D, et al. Latest evidence on immune checkpoint inhibitors in metastatic colorectal cancer: A 2022 update. Crit Rev Oncol Hematol. 2022;173:103663.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"11","key":"794_CR8","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1136\/gutjnl-2020-323505","volume":"70","author":"BJ Lawrence","year":"2021","unstructured":"Lawrence BJ, Alexander E, Grant H, et al. Colorectal cancer and absolute risks. Gut. 2021;70(11):2215\u20136.","journal-title":"Gut"},{"issue":"12","key":"794_CR9","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1016\/j.bbamcr.2013.06.026","volume":"1833","author":"P Paoli","year":"2013","unstructured":"Paoli P, Giannoni E, Chiarugi P. Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta. 2013;1833(12):3481\u201398.","journal-title":"Biochim Biophys Acta"},{"issue":"22","key":"794_CR10","doi-asserted-by":"publisher","first-page":"16188","DOI":"10.3390\/ijms242216188","volume":"24","author":"H Zhao","year":"2023","unstructured":"Zhao H, Huang Y, Tong G, et al. Identification of a Novel Oxidative Stress- and Anoikis-Related Prognostic Signature and Its Immune Landscape Analysis in NonSmall Cell Lung Cancer. Int J Mol Sci. 2023;24(22):16188.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"794_CR11","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41416-020-0970-z","volume":"123","author":"CF Mo","year":"2020","unstructured":"Mo CF, Li J, Yang SX, et al. IQGAP1 promotes anoikis resistance and metastasis through Rac1-dependent ROS accumulation and activation of Src\/FAK signalling in hepatocellular carcinoma. Br J Cancer. 2020;123(7):1154\u201363.","journal-title":"Br J Cancer"},{"key":"794_CR12","doi-asserted-by":"publisher","first-page":"154460","DOI":"10.1016\/j.prp.2023.154460","volume":"245","author":"X Yang","year":"2023","unstructured":"Yang X, Jia Q, Zou Z, et al. INHBB promotes tumor aggressiveness and stemness of glioblastoma via activating EGFR signaling. Pathol Res Pract. 2023;245:154460.","journal-title":"Pathol Res Pract"},{"issue":"11","key":"794_CR13","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1111\/cas.13780","volume":"109","author":"G Zou","year":"2018","unstructured":"Zou G, Ren B, Liu Y, et al. Inhibin B suppresses anoikis resistance and migration through the transforming growth factor-\u03b2 signaling pathway in nasopharyngeal carcinoma. Cancer Sci. 2018;109(11):3416\u201327.","journal-title":"Cancer Sci"},{"issue":"4","key":"794_CR14","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","volume":"50","author":"E Batlle","year":"2019","unstructured":"Batlle E, Massagu\u00e9 J. Transforming Growth Factor-\u03b2 Signaling in Immunity and Cancer. Immunity. 2019;50(4):924\u201340.","journal-title":"Immunity"},{"issue":"1","key":"794_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","volume":"18","author":"R Derynck","year":"2021","unstructured":"Derynck R, Turley SJ, Akhurst RJ. TGF\u03b2 biology in cancer progression and immunotherapy. Nat Rev Clin Oncol. 2021;18(1):9\u201334.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"794_CR16","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jds.2023.07.014","volume":"19","author":"YY Chung","year":"2024","unstructured":"Chung YY, Cheng SJ, Ko HH, et al. Evaluation of the prognostic and therapeutic potential of inhibin beta B for oral squamous cell carcinoma. J Dent Sci. 2024;19(1):448\u201354.","journal-title":"J Dent Sci"},{"issue":"10","key":"794_CR17","doi-asserted-by":"publisher","first-page":"e111276","DOI":"10.1371\/journal.pone.0111276","volume":"9","author":"I Wacker","year":"2014","unstructured":"Wacker I, Behrens J. Activin B antagonizes RhoA signaling to stimulate mesenchymal morphology and invasiveness of clear cell renal cell carcinomas. PLoS ONE. 2014;9(10):e111276.","journal-title":"PLoS ONE"},{"key":"794_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.canlet.2020.11.025","volume":"499","author":"Y Chen","year":"2021","unstructured":"Chen Y, Qian B, Sun X, et al. Sox9\/INHBB axis-mediated crosstalk between the hepatoma and hepatic stellate cells promotes the metastasis of hepatocellular carcinoma. Cancer Lett. 2021;499:243\u201354.","journal-title":"Cancer Lett"},{"issue":"10","key":"794_CR19","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41419-023-06187-z","volume":"14","author":"YD Chu","year":"2023","unstructured":"Chu YD, Cheng LC, Lim SN, et al. Aldolase B-driven lactagenesis and CEACAM6 activation promote cell renewal and chemoresistance in colorectal cancer through the Warburg effect. Cell Death Dis. 2023;14(10):660.","journal-title":"Cell Death Dis"},{"issue":"1","key":"794_CR20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/cancers14010252","volume":"14","author":"J Drury","year":"2022","unstructured":"Drury J, Rychahou PG, Kelson CO, et al. Upregulation of CD36, a Fatty Acid Translocase, Promotes Colorectal Cancer Metastasis by Increasing MMP28 and Decreasing E-Cadherin Expression. Cancers. 2022;14(1):252.","journal-title":"Cancers"},{"key":"794_CR21","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s00432-022-03957-8","volume":"148","author":"C Ruan","year":"2022","unstructured":"Ruan C, Meng Y, Song H. CD36: an emerging therapeutic target for cancer and its molecular mechanisms. J Cancer Res Clin Oncol. 2022;148:1551\u20138.","journal-title":"J Cancer Res Clin Oncol"},{"key":"794_CR22","doi-asserted-by":"crossref","unstructured":"Sipos F, Germann TM et al. MMP3 and CXCL1 are potent stromal protein markers of dysplasia\u2013carcinoma transition in sporadic colorectal cancer. Eur J Cancer Prev. 23(5):336\u201343.","DOI":"10.1097\/CEJ.0000000000000058"},{"issue":"10","key":"794_CR23","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1515\/hsz-2022-0103","volume":"403","author":"QC Zhu","year":"2022","unstructured":"Zhu QC, Sun JH, Liang MJ, et al. PHF20L1 mediates PAX2 expression to promote angiogenesis and liver metastasis in colorectal cancer through regulating HIC1. Biol Chem. 2022;403(10):917\u201328.","journal-title":"Biol Chem"},{"issue":"4","key":"794_CR24","doi-asserted-by":"publisher","first-page":"e70437","DOI":"10.1111\/jcmm.70437","volume":"29","author":"Y Wen","year":"2025","unstructured":"Wen Y, Liao J, Lu C, et al. Constructing a Prognostic Model for Subtypes of Colorectal Cancer Based on Machine Learning and Immune Infiltration-Related Genes. J Cell Mol Med. 2025;29(4):e70437.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"794_CR25","doi-asserted-by":"publisher","first-page":"110636","DOI":"10.1016\/j.ygeno.2023.110636","volume":"115","author":"Y Fang","year":"2023","unstructured":"Fang Y, Wu F, Shang G, et al. SCARA5 in bone marrow stromal cell-derived exosomes inhibits colorectal cancer progression by inactivating the PI3K\/Akt pathway. Genomics. 2023;115(4):110636.","journal-title":"Genomics"},{"issue":"12","key":"794_CR26","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1007\/s12094-022-02910-y","volume":"24","author":"L Tan","year":"2022","unstructured":"Tan L, Peng D, Cheng Y. Significant position of C-myc in colorectal cancer: a promising therapeutic target. Clin Transl Oncol. 2022;24(12):2295\u2013304.","journal-title":"Clin Transl Oncol"},{"key":"794_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2147\/CEG.S252157","volume":"13","author":"T Yoshida","year":"2020","unstructured":"Yoshida T, Miura T, Matsumiya T, et al. Toll-Like Receptor 3 as a Recurrence Risk Factor and a Potential Molecular Therapeutic Target in Colorectal Cancer. Clin Exp Gastroenterol. 2020;13:427\u201338.","journal-title":"Clin Exp Gastroenterol"},{"issue":"5","key":"794_CR28","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41419-022-04950-2","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, He H, Zhang F, et al. m6A methylated EphA2 and VEGFA throughIGF2BP2\/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K\/AKT and ERK1\/2 signaling. Cell Death Dis. 2022;13(5):483.","journal-title":"Cell Death Dis"},{"issue":"9","key":"794_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12032-023-02131-5","volume":"40","author":"M Tufail","year":"2023","unstructured":"Tufail M. HOTAIR in colorectal cancer: structure, function, and therapeutic potential. Med Oncol. 2023;40(9):259.","journal-title":"Med Oncol"},{"issue":"5","key":"794_CR30","doi-asserted-by":"publisher","first-page":"8550","DOI":"10.18632\/oncotarget.14347","volume":"8","author":"YA Cho","year":"2017","unstructured":"Cho YA, Lee J, Oh JH, et al. Genetic variation in PPARGC1A may affect the role of diet-associated inflammation in colorectal carcinogenesis. Oncotarget. 2017;8(5):8550\u20138.","journal-title":"Oncotarget"},{"key":"794_CR31","doi-asserted-by":"crossref","unstructured":"Yuan J, Xie A, Cao Q, et al. INHBB is a novel prognostic biomarker associated with cancer-promoting pathways in colorectal cancer. Biomed Res Int. 2020; 2020:6909672.","DOI":"10.1155\/2020\/6909672"},{"issue":"10","key":"794_CR32","doi-asserted-by":"publisher","first-page":"e70947","DOI":"10.1002\/cam4.70947","volume":"14","author":"I Attique","year":"2025","unstructured":"Attique I, Haider Z, Khan M, et al. Reactive Oxygen Species: From Tumorigenesis to Therapeutic Strategies in Cancer. Cancer Med. 2025;14(10):e70947.","journal-title":"Cancer Med"},{"issue":"10","key":"794_CR33","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3390\/antiox14101187","volume":"14","author":"JS Ranbhise","year":"2025","unstructured":"Ranbhise JS, Singh MK, Ju S, et al. The redox paradox: cancer\u2019s double-edged sword for malignancy and therapy. Antioxid (Basel). 2025;14(10):1187. Published 2025 Sep 28.","journal-title":"Antioxid (Basel)"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00794-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00794-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00794-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T02:52:53Z","timestamp":1778208773000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00794-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["794"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00794-4","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. A statement to confirm that all methods were carried out in accordance with relevant guidelines and regulations. A statement to confirm that all experimental protocols were approved by licensing committee. This experiment was approved by the 900 Hospital Ethics Society (Project No. 2025-010).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}